DVA Stock: DaVita Inc. Stock Price, Analysis & Insights
Get live dva stock price $131.16, comprehensive DaVita Inc. stock analysis, charts, news, and expert forecast. Real-time dva stock data and investment insights.
Company Overview
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Company Information
- CEO
- Javier J. Rodriguez
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 76000
Contact Information
- Website
- https://www.davita.com
- Address
- 2000 16th Street
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 9.38B market capitalization
- Trading Volume: 777.37K shares traded today
- Price Range: 52-week range of $126.07 - $179.60
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for DaVita Inc.
DaVita Inc. (DVA) operates in the Medical - Care Facilities industry within the Healthcare sector. With a current market capitalization of 9.38B, the company represents a significant player in its market. The stock is currently trading at $131.16 with a negativedaily change of 0.71%.
The company's 76000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 12.92, beta of 1.12, and 52-week price range from $126.07 to $179.60when evaluating investment opportunities.
Why Invest in DaVita Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Javier J. Rodriguez
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.